An Evaluation of the Safety and Efficacy of Moxifloxacin Ophthalmic Solution 0.5% ((VIGAMOX®) Versus Ofloxacin Ophthalmic Solution 0.3% in the Treatment of Bacterial Conjunctivitis in Chinese Patients

NCT01573910 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

985

Enrollment

INDUSTRY

Sponsor class

Conditions

Bacterial Conjunctivitis

Interventions

DRUG: Moxifloxacin ophthalmic solution, 0.5%
DRUG: Ofloxacin ophthalmic solution, 0.3%

Sponsor

Alcon Research